NCT06232083 2025-07-09
A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)
Anhui Provincial Hospital
Phase 1 Recruiting
Clinical Trials
5 trialsNCT06846424 2025-02-26
SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer
Shanghai Gynecologic Oncology Group
Phase 1 Not yet recruiting
NCT06760676 2025-01-07
A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy
Anhui Provincial Hospital
Phase 1 Not yet recruiting
NCT02521844 2024-10-08
A Study to Evaluate the Safety and Tolerability of ETC-1922159 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumours
EDDC (Experimental Drug Development Centre), A*STAR Research Entities
Phase 1 Active not recruiting
NCT06415500 2024-05-16
A Study on the Safety and Preliminary Efficacy of NK042 in the Treatment of Malignant Ascites
Anhui Provincial Hospital
Phase 1 Not yet recruiting